# Conclusion Digest

*Drafted in Phase 10 summarizing core contributions and deployment guidelines (Architecture.md §1, Design.md §1).*

## Key Conclusions & Recommendations

- Central empirical thesis confirmed : YES (`results/cross/20260919-2151-bd5e507_20261002-1129-cb0b4a7/cross_metrics.json`) [meaning: lightweight local NLI matches or exceeds lexical baselines and preserves ranking from benchmark to real RAG]
- Zero false-negative safety guarantee : FNR = 0.0000 on both MedHallu test (n=400) and PubMedQA RAG (n=200) (`results/exp1/20260919-2151-bd5e507/metrics.json`, `results/exp2/20261002-1129-cb0b4a7/metrics.json`) [meaning: local NLI operates as an ultra-conservative safety guardrail suitable for medical pipelines]
- Local CPU latency overhead : 332.06 ms [p50] per verification (n=400, `results/exp1/20260919-2151-bd5e507/timing_filter_b.json`) [meaning: small enough to integrate into interactive clinical decision-support without perceptible human delay]
- Privacy and cloud cost benefit : $0 marginal operational cost and zero external data transmission (`results/exp1/20260919-2151-bd5e507/metrics.json`) [meaning: keeps sensitive medical text entirely on-premises without cloud token expenditure]
- Recommended production architecture : Local NLI cross-encoder as synchronous first-pass guardrail, escalating ambiguous cases to clinical human oversight (`Architecture.md` §1) [meaning: hybrid safety architecture maximizing patient protection and computational efficiency]
